✦ LIBER ✦

P128 Safety and tolerability data from the ATAC(‘arimidex’, tamoxifen, alone or in combination) trial after completion of 5 years' adjuvant treatment

✍ Scribed by Wolfgang Distler

Book ID: 114315851
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 51 KB
Volume: 14
Category: Article
ISSN: 0960-9776
DOI: 10.1016/s0960-9776(05)80164-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P127 Efficacy data from the ATAC (“arimi

P127 Efficacy data from the ATAC (“arimidex”, tamoxifen, alone or in combination) trial after completion of 5 years' adjuvant treatment

✍ Tony Howell 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 50 KB

Results of the ATAC (Arimidex, Tamoxifen

Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer

📂 Article 📅 2005 🏛 The Lancet 🌐 English ⚖ 66 KB

Results of the ATAC (Arimidex, Tamoxifen

Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) Trial After Completion of 5 Years' Adjuvant Treatment for Breast Cancer

✍ Cianfrocca, M.E.; Gradishar, W.J. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 93 KB

Quality of Life of Postmenopausal Women

Quality of Life of Postmenopausal Women in the ATAC (“Arimidex”, Tamoxifen, Alone or in Combination) Trial after Completion of 5

✍ David Cella; Lesley Fallowfield; Peter Barker; Jack Cuzick; Gershon Locker; Anth 📂 Article 📅 2006 🏛 Springer US 🌐 English ⚖ 205 KB

Anastrozole alone or in combination with

Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early-stage breast cancer : Results of the ATAC (Arimidex, Tamoxifen Alone or in Combination) trial efficacy and safety update analyses

✍ The ATAC (Arimidex; Tamoxifen Alone or in Combination) Trialists' Group 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB 👁 2 views

## Abstract ## BACKGROUND The first analysis of the ATAC (Arimidex, Tamoxifen Alone or in Combination) trial (median follow‐up, 33 months) demonstrated that in adjuvant endocrine therapy for postmenopausal patients with early‐stage breast cancer, anastrozole was superior to tamoxifen in terms of d

0130 Initial adjuvant therapy with anast

0130 Initial adjuvant therapy with anastrozole - early- and late-event data from the arimidex, tamoxifen, alone or in combination (ATAC) trial in the hormone-responsive population

✍ A. Howell; J. Forbes; J. Cuzick 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 52 KB